Stockreport

ImmunityBio and nCartes partner to automate clinical trial data processes [Yahoo! Finance]

ImmunityBio, Inc.  (IBRX) 
PDF This aims to reduce costs, improve data quality, and speed up the process, which is currently manual and prone to errors. The partnership is expected to benefit Immunity [Read more]